Ambrisentan has a more favourable hepatic safety profile compared to bosentan, with lower incidence of aminotransferase elevations — however, liver mo...
Always confirm PAH diagnosis with right heart catheterisation before initiating bosentan — empiric use for other forms of pulmonary hypertension is in...